Page 175 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine: Bangladesh signs agreement with Serum Institute of India The COVID-19 fatality rate in Bangladesh is now 1.44 per cent and the current recovery rate is 85.80 per cent. Vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca. AFP Photo Bangladesh on Sunday signed an agreement with the Pune-based Serum Institute of India (SII) for procurement of three crore doses of the Oxford-Astrazeneca COVID-19 vaccine. According to DD News, the vaccine will be delivered in six installments of 50 lakh doses each. After signing of the agreement, Bangladesh Health Minister Zahed Maleq said that the vaccine has proved safe during trials in different countries and it is suitable for Bangladesh. He also said the government is in talks with other countries to procure more doses of the COVID-19 vaccine.

Zahed maleqHealth servicesBangladesh healthSerum institute of indiaPune based serum instituteBangladesh health minister zahed maleqDirectorate generalஆரோக்கியம் சேவைகள்பங்களாதேஷ் ஆரோக்கியம்சீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்இயக்குநரகம் ஜநரல்